journal article·2025-05-13Open access

A Review of Neuro-ML Breakthroughs in Addressing Neurological Disorders

Cosmina-Mihaela Rosca, Adrian Stancu

Applied Sciences· Volume 15· Issue 10

Abstract

This research aims to explore the interdisciplinary connection between the field of neurology and artificial intelligence (AI) through machine learning (ML) algorithms. The central objective is to evaluate the current state of research in the Neuro-ML field and identify gaps in the literature that require additional approaches. To achieve this objective, 10 analyses were introduced that analyze the distribution of articles based on keywords, countries, years, publishers, and ML algorithms used in the context of neurological diseases. Surveys were also conducted to identify the diseases most frequently studied through ML algorithms. Thus, it was found that Alzheimer’s disease (37 articles for Support Vector Regression—SVR; 31 for Random Forest—RF), Parkinson’s disease (46 articles for SVM and 48 for RF), and multiple sclerosis (9 articles for SVM) are the most studied diseases in the field of Neuro-ML. The study analyzes Alzheimer’s, Parkinson’s, and multiple sclerosis in detail by focusing on diagnosis. The overall results highlight an increase in researchers’ interest in applying ML in neurology, with models such as SVM (597 articles), Artificial Neural Network (525 articles), and RF (457 articles) being the most used. The results highlighted three major gaps: the underrepresentation of rare diseases, the lack of standardization in evaluating the performance of ML models, and the lack of exploration of algorithms with greater implementation difficulty, such as Extreme Gradient Boosting and Multilayer Perceptron. The value analysis of the performance metrics of ML models demonstrates the ability to correctly classify neuro-degenerative diseases, with high accuracy in some cases (for example, 97.46% accuracy in Alzheimer’s diagnosis), but there may still be improvements. Future directions include exploring rare diseases, investigating underutilized algorithms, and developing standardized protocols for evaluating the performance of ML models, which will facilitate the comparison of results across different studies.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neurological disorders and treatments · Brain Tumor Detection and Classification · Neuroscience and Neural Engineering

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Automatic Control, Computers, and Electronics, Faculty of Mechanical and Electrical Engineering, Petroleum-Gas University of Ploiesti, 39 Bucharest Avenue, 100680 Ploiesti, Romania

Department of Business Administration, Faculty of Economic Sciences, Petroleum-Gas University of Ploiesti, 39 Bucharest Avenue, 100680 Ploiesti, Romania

Funding

Petroleum-Gas University of Ploiesti

References (100+)

Show source-provided references
1. Rosca, C.-M., Stancu, A., and Tănase, M.R. (2025). A Comparative Study of Azure Custom Vision Versus Google Vision API Integrated into AI Custom Models Using Object Classification for Residential Waste. Appl. Sci., 15.10.3390/app15073869 ↗
2. Rosca, C.-M., Stancu, A., Neculaiu, C.-F., and Gortoescu, I.-A. (2024). Designing and Implementing a Public Urban Transport Scheduling System Based on Artificial Intelligence for Smart Cities. Appl. Sci., 14.10.3390/app14198861 ↗
3. Rosca, C.-M., and Stancu, A. (2024). Earthquake Prediction and Alert System Using IoT Infrastructure and Cloud-Based Environmental Data Analysis. Appl. Sci., 14.10.3390/app142210169 ↗
4. Popescu, C., Dissanayake, H., Mansi, E., and Stancu, A. (2024). Eco Breakthroughs: Sustainable Materials Transforming the Future of Our Planet. Sustainability, 16.10.3390/su162310790 ↗
5. Alshehri, S., Alahmari, K.A., and Alasiry, A. (2024). A Comprehensive Evaluation of AI-Assisted Diagnostic Tools in ENT Medicine: Insights and Perspectives from Healthcare Professionals. J. Pers. Med., 14.10.3390/jpm14040354 ↗
6. Application and potential of artificial intelligence in neonatal medicine10.1016/j.siny.2022.101346 ↗
7. Joshi, G., Jain, A., Araveeti, S.R., Adhikari, S., Garg, H., and Bhandari, M. (2024). FDA-Approved Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices: An Updated Landscape. Electronics, 13.10.3390/electronics13030498 ↗
8. Digital pathology and artificial intelligence in translational medicine and clinical practice10.1038/s41379-021-00919-2 ↗
9. Passaro, A.P., Lebos, A.L., Yao, Y., and Stice, S.L. (2021). Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk. Front. Immunol., 12.10.3389/fimmu.2021.676621 ↗
10. Neurological Implications of COVID-19 Infections10.1007/s12028-020-00978-4 ↗
11. Rosca, C.-M., and Stancu, A. (2024). Fusing Machine Learning and AI to Create a Framework for Employee Well-Being in the Era of Industry 5.0. Appl. Sci., 14.10.3390/app142310835 ↗
12. Neurological Voice Disorders: A Review10.5005/jp-journals-10001-1521 ↗
13. Waris, A., Ali, A., Khan, A.U., Asim, M., Zamel, D., Fatima, K., Raziq, A., Khan, M.A., Akbar, N., and Baset, A. (2022). Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders. Nanomaterials, 12.10.3390/nano12132140 ↗
14. Ashraf, H., Solla, P., and Sechi, L.A. (2022). Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases. Pharmaceuticals, 15.10.3390/ph15091077 ↗
15. Genome-wide association studies identify novel loci in rapidly progressive Alzheimer’s disease10.1002/alz.13655 ↗
16. Saleem, T.J., Zahra, S.R., Wu, F., Alwakeel, A., Alwakeel, M., Jeribi, F., and Hijji, M. (2022). Deep Learning-Based Diagnosis of Alzheimer’s Disease. J. Pers. Med., 12.10.3390/jpm12050815 ↗
17. Classification of Parkinson’s Disease using Speech Signal with Machine Learning and Deep Learning Approaches10.24018/ejece.2023.7.2.488 ↗
18. Zeng, Q., Shen, J., Chen, K., Zhou, J., Liao, Q., Lu, K., Yuan, J., and Bi, F. (2020). The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients. Sci. Rep., 10.10.1038/s41598-020-69845-8 ↗
19. Phylogenetic analysis of microRNA biomarkers for amyotrophic lateral sclerosis10.32604/biocell.2021.014343 ↗
20. Frequency of C9orf72, GRN, and MAPT pathogenic variants in patients recruited at the Belgrade Memory Center10.1007/s10048-024-00766-8 ↗
21. Reviewing Biochemical Implications of Normal and Mutated Huntingtin in Huntington’s Disease10.2174/0929867326666190621101909 ↗
22. Translating cell therapies for neurodegenerative diseases: Huntington’s disease as a model disorder10.1093/brain/awac086 ↗
23. Ratner, M.H., and Rutchik, J.S. (2024). A rare case of early onset lewy body dementia with parkinsonism associated with chronic exposure to copper contaminated drinking water. Front. Toxicol., 6.10.3389/ftox.2024.1451235 ↗
24. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases10.1093/brain/awab350 ↗
25. Kuru Disease: Bridging the Gap Between Prion Biology and Human Health
26. Primary degeneration of oculomotor, motor, and somatosensory systems and auditory and visual pathways in spinocerebellar ataxia type 7: A clinicopathological study in a Japanese autopsy case10.1111/neup.12869 ↗
27. Cerebellar cognitive-affective syndrome preceding ataxia associated with complex extrapyramidal features in a Turkish SCA48 family10.1007/s10048-019-00595-0 ↗
28. Spinocerebellar ataxia type 14 (SCA14) in an Argentinian family: A case report10.1186/s13256-023-03897-y ↗
29. Distinctive sphingolipid patterns in chronic multiple sclerosis lesions10.1194/jlr.RA120001022 ↗
30. Serum level of brain-derived neurotrophic factor in patients with relapsing–remitting multiple sclerosis: A potential biomarker for disease activity10.1186/s41983-021-00296-2 ↗
31. A Comparative Analysis of Sorting Algorithms for Large-Scale Data: Performance Metrics and Language Efficiency10.1007/978-981-97-5703-9_8 ↗
32. Rosca, C.-M., and Stancu, A. (2025). A Comprehensive Review of Machine Learning Models for Optimizing Wind Power Processes. Appl. Sci., 15.10.3390/app15073758 ↗
33. SSH Application Classification Based on Machine Learning
34. Sharp, J. (2022). Exam Ref AI-900 Microsoft Azure AI Fundamentals, Pearson Education.
35. Artificial Intelligence—Powered Video Content Generation Tools
36. A Systematic Literature Review on Multi-Label Classification based on Machine Learning Algorithms10.18421/TEM112-20 ↗
37. Machine learning algorithms review10.54254/2755-2721/4/20230355 ↗
38. Application of Machine Learning Techniques to Detect the Children with Autism Spectrum Disorder10.1155/2022/9340027 ↗
39. Algorithm for child adoption process using artificial intelligence and monitoring system for children10.1016/j.iot.2024.101170 ↗
40. Ramadurgam, S., and Perera, D.G. (2021). An Efficient FPGA-Based Hardware Accelerator for Convex Optimization-Based SVM Classifier for Machine Learning on Embedded Platforms. Electronics, 10.10.3390/electronics10111323 ↗
41. A Research on Image Recognition and Classification Based on Traditional Machine Learning and Deep Learning
42. Blended Learning for Machine Learning-based Image Classification10.4108/eetel.4509 ↗
43. Optimizing Neurodegenerative Disease Classification with Canny Segmentation and Voting Classifier: An Imbalanced Dataset Study
44. Machine Learning Algorithms for Classification Patients with Parkinson’s Disease and Hereditary Ataxias10.24138/jcomss-2022-0157 ↗
45. Tian, J., Smith, G., Guo, H., Liu, B., Pan, Z., Wang, Z., Xiong, S., and Fang, R. (2021). Modular machine learning for Alzheimer’s disease classification from retinal vasculature. Sci. Rep., 11.10.1038/s41598-020-80312-2 ↗
46. Phenotype parallels protein seeding capacity in neurodegenerative diseases10.1111/bpa.13238 ↗
47. Spatially informed Bayesian neural network for neurodegenerative diseases classification10.1002/sim.9604 ↗
48. A deep learning model for detection of Alzheimer’s disease based on retinal photographs: A retrospective, multicentre case-control study10.1016/S2589-7500(22)00169-8 ↗
49. Retinal imaging in Alzheimer’s and neurodegenerative diseases10.1002/alz.12179 ↗
50. A Comprehensive Patient Triage Algorithm Incorporating ChatGPT API for Symptom-Based Healthcare Decision-Making10.1007/978-981-97-5703-9_13 ↗
51. Predictive value of machine learning in diagnosing cognitive impairment in patients with Parkinson’s disease: A systematic review and meta-analysis10.21037/apm-22-1396 ↗
52. Comparative Analysis of Object Classification Algorithms: Traditional Image Processing Versus Artificial Intelligence-Based Approach
53. Artificial intelligence and machine learning in precision and genomic medicine10.1007/s12032-022-01711-1 ↗
54. Chang, C.-H., Lin, C.-H., and Lane, H.-Y. (2021). Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease. Int. J. Mol. Sci., 22.10.3390/ijms22052761 ↗
55. Yi, F., Yang, H., Chen, D., Qin, Y., Han, H., Cui, J., Bai, W., Ma, Y., Zhang, R., and Yu, H. (2023). XGBoost-SHAP-based interpretable diagnostic framework for alzheimer’s disease. BMC Med. Inform. Decis. Mak., 23.10.1186/s12911-023-02238-9 ↗
56. Deep Learning Approach for Early Detection of Alzheimer’s Disease10.1007/s12559-021-09946-2 ↗
57. Agostinho, D., Caramelo, F., Moreira, A.P., Santana, I., Abrunhosa, A., and Castelo-Branco, M. (2022). Combined Structural MR and Diffusion Tensor Imaging Classify the Presence of Alzheimer’s Disease With the Same Performance as MR Combined With Amyloid Positron Emission Tomography: A Data Integration Approach. Front. Neurosci., 15.10.3389/fnins.2021.638175 ↗
58. Machine Learning Analysis of Alzheimer’s Disease Single-Cell RNA-Sequencing Data across Cortex and Hippocampus Regions10.3390/cimb45110544 ↗
59. Zhou, B., Wei, J., Zhang, Y., Liu, Y., Shan, S., Ye, S., Li, B., Fan, D., and Luo, Y. (2022). Different observation period of exercise training in amyotrophic lateral sclerosis patients: A meta-analysis. Front. Neurol., 13.10.3389/fneur.2022.986882 ↗
60. Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis10.1093/braincomms/fcac207 ↗
61. Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis10.1212/WNL.0000000000009322 ↗
62. Prime time for machine learning to predict clinical outcomes in valvular heart disease?10.1002/ejhf.2379 ↗
63. Local clinical informatics investments are required for in silico biomarker generation across the globe: Lessons learned from a secondary analysis of the PROP trial
64. Analysis of SOD1 and C9orf72 mutations in patients with amyotrophic lateral sclerosis in Antioquia, Colombia10.7705/biomedica.6060 ↗
65. Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease10.1172/JCI131838 ↗
66. Comparative analysis of neurofilaments and biomarkers of muscular damage in amyotrophic lateral sclerosis10.1093/braincomms/fcae288 ↗
67. Staging model for amyotrophic lateral sclerosis in Singapore10.11622/smedj.2021001 ↗
68. Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis10.1002/mus.27724 ↗
69. Unlocking Customer Sentiment Insights with Azure Sentiment Analysis: A Comprehensive Review and Analysis
70. Salvi, M., Molinari, F., Ciccarelli, M., Testi, R., Taraglio, S., and Imperiale, D. (2023). Quantitative analysis of prion disease using an AI-powered digital pathology framework. Sci. Rep., 13.10.1038/s41598-023-44782-4 ↗
71. Evaluation of a New Criterion for Detecting Prion Disease With Diffusion Magnetic Resonance Imaging10.1001/jamaneurol.2020.1319 ↗
72. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain10.1002/glia.24244 ↗
73. Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis10.1093/brain/awac077 ↗
74. Frontotemporal dementia10.1503/cmaj.230407 ↗
75. Urine as matrix for analysis of neurofilament light chain is not suitable to distinguish frontotemporal dementia from psychiatric diseases10.1093/braincomms/fcad120 ↗
76. Battineni, G., Chintalapudi, N., Hossain, M.A., Losco, G., Ruocco, C., Sagaro, G.G., Traini, E., Nittari, G., and Amenta, F. (2022). Artificial Intelligence Models in the Diagnosis of Adult-Onset Dementia Disorders: A Review. Bioengineering, 9.10.3390/bioengineering9080370 ↗
77. Mohammed, B.A., Senan, E.M., Rassem, T.H., Makbol, N.M., Alanazi, A.A., Al-Mekhlafi, Z.G., Almurayziq, T.S., and Ghaleb, F.A. (2021). Multi-Method Analysis of Medical Records and MRI Images for Early Diagnosis of Dementia and Alzheimer’s Disease Based on Deep Learning and Hybrid Methods. Electronics, 10.10.3390/electronics10222860 ↗
78. Diagnosis of Alzheimer’s disease and behavioural variant frontotemporal dementia with machine learning-aided neuropsychological assessment using feature engineering and genetic algorithms
79. Yang, X.-S. (2025). Convergence Catalysts: Exploring the Fusion of Embedded Systems, IoT, and Artificial Intelligence. Engineering Applications of AI and Swarm Intelligence, Springer Nature.10.1007/978-981-97-5979-8 ↗
80. Corpus Callosum Atrophy in Detection of Mild and Moderate Alzheimer’s Disease Using Brain Magnetic Resonance Image Processing and Machine Learning Techniques10.3233/ADR-210314 ↗
81. Zadgaonkar, A., Keskar, R., and Kakde, O. (2023). Towards a Machine Learning Model for Detection of Dementia Using Lifestyle Parameters. Appl. Sci., 13.10.3390/app131910630 ↗
82. Miltiadous, A., Tzimourta, K.D., Afrantou, T., Ioannidis, P., Grigoriadis, N., Tsalikakis, D.G., Angelidis, P., Tsipouras, M.G., Glavas, E., and Giannakeas, N. (2023). A Dataset of Scalp EEG Recordings of Alzheimer’s Disease, Frontotemporal Dementia and Healthy Subjects from Routine EEG. Data, 8.10.3390/data8060095 ↗
83. Lau, A., Beheshti, I., Modirrousta, M., Kolesar, T.A., Goertzen, A.L., and Ko, J.H. (2021). Alzheimer’s Disease-Related Metabolic Pattern in Diverse Forms of Neurodegenerative Diseases. Diagnostics, 11.10.3390/diagnostics11112023 ↗
84. A Deep Learning Approach to Predicting Disease Progression in Multiple Sclerosis Using Magnetic Resonance Imaging10.1097/RLI.0000000000000854 ↗
85. Arrambide, G., Comabella, M., and Tur, C. (2024). Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosis. Front. Immunol., 15.10.3389/fimmu.2024.1459502 ↗
86. Aslam, N., Khan, I.U., Bashamakh, A., Alghool, F.A., Aboulnour, M., Alsuwayan, N.M., Alturaif, R.A.K., Brahimi, S., Aljameel, S.S., and Al Ghamdi, K. (2022). Multiple Sclerosis Diagnosis Using Machine Learning and Deep Learning: Challenges and Opportunities. Sensors, 22.10.3390/s22207856 ↗
87. Serum and Cerebrospinal Fluid Cytokine Biomarkers for Diagnosis of Multiple Sclerosis10.1155/2020/2727042 ↗
88. Enhancing trustworthiness and reliability: Advance explainable artificial intelligence framework for real world Sclerosis detection10.1088/1402-4896/ad72b0 ↗
89. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorders by multiparametric quantitative MRI using convolutional neural network10.1016/j.jocn.2021.02.018 ↗
90. Sun, X., Ren, X., Zhang, J., Nie, Y., Hu, S., Yang, X., and Jiang, S. (2022). Discovering miRNAs Associated With Multiple Sclerosis Based on Network Representation Learning and Deep Learning Methods. Front. Genet., 13.10.3389/fgene.2022.899340 ↗
91. New Algorithm to Prevent Online Test Fraud Based on Cognitive Services and Input Devices Events
92. Early Detection of Parkinson’s Disease Using Deep Learning and Machine Learning10.1109/ACCESS.2020.3016062 ↗
93. Multi-modality machine learning predicting Parkinson’s disease10.1038/s41531-022-00288-w ↗
94. Spinocerebellar ataxia type 11 (SCA11): An update10.1111/ejn.16054 ↗
95. Prognoza: Parkinson’s Disease Prediction Using Classification Algorithms10.4108/eetpht.9.3933 ↗
96. Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s Disease10.3390/biomedinformatics4010009 ↗
97. Giannakopoulou, K.-M., Roussaki, I., and Demestichas, K. (2022). Internet of Things Technologies and Machine Learning Methods for Parkinson’s Disease Diagnosis, Monitoring and Management: A Systematic Review. Sensors, 22.10.3390/s22051799 ↗
98. Tran, C., Shen, K., Liu, K., Ashok, A., Ramirez-Zamora, A., Chen, J., Li, Y., and Fang, R. (2024). Deep learning predicts prevalent and incident Parkinson’s disease from UK Biobank fundus imaging. Sci. Rep., 14.10.1038/s41598-024-54251-1 ↗
99. Classification of Parkinson’s disease patients based on spectrogram using local binary pattern descriptors10.1088/1742-6596/2153/1/012014 ↗
100. Deep learning-based scheme to diagnose Parkinson’s disease10.1111/exsy.12739 ↗